[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [@JStonker](/creator/twitter/JStonker) "Some interesting #AVCT coverage published in China this afternoon by WuXi AppTec - "a global pharmaceutical biopharmaceutical and medical device company" with a $25bn market cap" [X Link](https://x.com/JStonker/status/1901708312330011068) [@JStonker](/creator/x/JStonker) 2025-03-17T18:52Z XXX followers, 13.4K engagements "Another mention for #AVCT from WuXi AppTec published this morning" [X Link](https://x.com/JStonker/status/1901905379686015166) [@JStonker](/creator/x/JStonker) 2025-03-18T07:55Z XXX followers, 3397 engagements "'Achieving precise tumor targeting + minimizing systemic toxicity addresses fundamental challenges in cancer treatment.' Interesting new article from Wuxi AppTec on peptide therapeutics/conjugates. #AVCT" [X Link](https://x.com/JStonker/status/1975291708524142846) [@JStonker](/creator/x/JStonker) 2025-10-06T20:06Z XXX followers, 6998 engagements
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
@JStonker
"Some interesting #AVCT coverage published in China this afternoon by WuXi AppTec - "a global pharmaceutical biopharmaceutical and medical device company" with a $25bn market cap"
X Link @JStonker 2025-03-17T18:52Z XXX followers, 13.4K engagements
"Another mention for #AVCT from WuXi AppTec published this morning"
X Link @JStonker 2025-03-18T07:55Z XXX followers, 3397 engagements
"'Achieving precise tumor targeting + minimizing systemic toxicity addresses fundamental challenges in cancer treatment.' Interesting new article from Wuxi AppTec on peptide therapeutics/conjugates. #AVCT"
X Link @JStonker 2025-10-06T20:06Z XXX followers, 6998 engagements
/creator/twitter::1245271176919822337/posts